Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03508726 · ClinicalTrials.gov registry record · Phase 1
High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas
A Phase 1 study, sponsored by Mohammed Milhem.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
NCT03508726 is a Phase 1 study that has completed, run by Mohammed Milhem. The registered enrollment target is 25 participants.
The verdict
NCT03508726, a Phase 1 study, has completed, sponsored by Mohammed Milhem.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
This is a single-arm open-label phase Ib/II clinical study assessing the efficacy of concurrent high dose ascorbate in combination with radiotherapy in patients with locally advanced, resectable, high grade sarcomas.
Interventions
- DRUG Ascorbate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-06-27 |
| Est. Completion | 2024-06-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03508726
The ClinicalTrials.gov registry entry for NCT03508726 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mohammed Milhem, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ascorbate is the first listed.
NCT03508726 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03508726 about?
NCT03508726 is a clinical study titled "High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas". This is a single-arm open-label phase Ib/II clinical study assessing the efficacy of concurrent high dose ascorbate in combination with radiotherapy in patients with locally advanced, resectable, high grade sarcomas.
What is the current status of trial NCT03508726?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2019-06-27. Estimated completion is 2024-06-02.
What interventions are being tested in trial NCT03508726?
The interventions under investigation include: Ascorbate (DRUG).
Who is sponsoring clinical trial NCT03508726?
This trial is sponsored by Mohammed Milhem, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.